SUSQUEHANNA INTERNATIONAL GROUP, LLP - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,283,924
+154.6%
391,226
+207.9%
0.00%
Q2 2023$1,682,552
+20.9%
127,081
+24.3%
0.00%
Q1 2023$1,391,527
+77.0%
102,243
+154.0%
0.00%
Q4 2022$786,024
+0.3%
40,247
-2.2%
0.00%
Q3 2022$784,000
-53.1%
41,162
-49.3%
0.00%
Q2 2022$1,671,000
-0.8%
81,115
+54.9%
0.00%
Q1 2022$1,685,000
-76.5%
52,367
-65.9%
0.00%
Q4 2021$7,156,000
+935.6%
153,700
+470.5%
0.00%
Q2 2021$691,000
+0.1%
26,939
+33.4%
0.00%
Q1 2021$690,00020,1920.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$37,274,86415.53%
MPM BioImpact LLC 1,745,943$23,762,2846.17%
Saturn V Capital Management LP 480,653$6,541,6874.89%
Boxer Capital, LLC 2,154,058$29,3171.44%
RA Capital Management 4,417,259$60,118,8951.36%
Octagon Capital Advisors LP 596,000$8,111,5601.17%
BVF INC/IL 1,810,835$24,645,4640.90%
AlphaCentric Advisors LLC 63,000$857,4300.59%
Integral Health Asset Management, LLC 180,000$2,449,8000.49%
683 Capital Management, LLC 480,000$6,532,8000.49%
View complete list of ITEOS THERAPEUTICS INC shareholders